UBS Group’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-833,464
| Closed | -$126M | – | 10674 |
|
|
2022
Q3 | $126M | Buy |
833,464
+559,438
| +204% | +$84.6M | 0.06% | 265 |
|
|
2022
Q2 | $39.9M | Buy |
274,026
+236,397
| +628% | +$34.4M | 0.02% | 649 |
|
|
2022
Q1 | $4.46M | Buy |
37,629
+25,883
| +220% | +$3.07M | ﹤0.01% | 2015 |
|
|
2021
Q4 | $1.62M | Buy |
11,746
+5,701
| +94% | +$786K | ﹤0.01% | 3042 |
|
|
2021
Q3 | $839K | Buy |
6,045
+1,506
| +33% | +$209K | ﹤0.01% | 3377 |
|
|
2021
Q2 | $441K | Sell |
4,539
-34,821
| -88% | -$3.38M | ﹤0.01% | 3837 |
|
|
2021
Q1 | $2.69M | Buy |
39,360
+18,100
| +85% | +$1.24M | ﹤0.01% | 2500 |
|
|
2020
Q4 | $1.82M | Buy |
21,260
+19,757
| +1,315% | +$1.69M | ﹤0.01% | 2695 |
|
|
2020
Q3 | $98K | Sell |
1,503
-440
| -23% | -$28.7K | ﹤0.01% | 4371 |
|
|
2020
Q2 | $142K | Buy |
1,943
+795
| +69% | +$58.1K | ﹤0.01% | 4247 |
|
|
2020
Q1 | $39K | Buy |
1,148
+164
| +17% | +$5.57K | ﹤0.01% | 5143 |
|
|
2019
Q4 | $54K | Sell |
984
-101,495
| -99% | -$5.57M | ﹤0.01% | 5270 |
|
|
2019
Q3 | $4.28M | Buy |
102,479
+95,576
| +1,385% | +$3.99M | ﹤0.01% | 1981 |
|
|
2019
Q2 | $302K | Buy |
6,903
+2,726
| +65% | +$119K | ﹤0.01% | 3866 |
|
|
2019
Q1 | $215K | Sell |
4,177
-8,501
| -67% | -$438K | ﹤0.01% | 3814 |
|
|
2018
Q4 | $469K | Sell |
12,678
-1,343
| -10% | -$49.7K | ﹤0.01% | 3553 |
|
|
2018
Q3 | $527K | Buy |
14,021
+10,661
| +317% | +$401K | ﹤0.01% | 3597 |
|
|
2018
Q2 | $133K | Buy |
3,360
+1,046
| +45% | +$41.4K | ﹤0.01% | 4379 |
|
|
2018
Q1 | $60K | Sell |
2,314
-245
| -10% | -$6.35K | ﹤0.01% | 4746 |
|
|
2017
Q4 | $69K | Buy |
2,559
+2,190
| +593% | +$59.1K | ﹤0.01% | 4668 |
|
|
2017
Q3 | $14K | Buy |
+369
| New | +$14K | ﹤0.01% | 5815 |
|